DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Prairie Wealth Advisors Inc.

Prairie Wealth Advisors Inc. lessened its position in shares of DocuSign, Inc. (NASDAQ:DOCU) by 6.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,399 shares of the company’s stock after selling 620 shares during the period. Prairie Wealth Advisors Inc.’s holdings in DocuSign were worth $755,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of DOCU. State Street Corp lifted its position in shares of DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after buying an additional 120,743 shares during the last quarter. Geode Capital Management LLC lifted its position in DocuSign by 1.6% in the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock valued at $215,789,000 after acquiring an additional 53,554 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in DocuSign by 5.2% in the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock valued at $141,398,000 after acquiring an additional 112,919 shares in the last quarter. FMR LLC grew its holdings in shares of DocuSign by 16.8% during the third quarter. FMR LLC now owns 2,192,885 shares of the company’s stock worth $136,156,000 after purchasing an additional 315,073 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of DocuSign by 14.4% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,659,367 shares of the company’s stock worth $103,030,000 after purchasing an additional 208,813 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Stock Performance

DocuSign stock opened at $93.85 on Friday. The company has a market cap of $18.96 billion, a P/E ratio of 19.35, a price-to-earnings-growth ratio of 8.74 and a beta of 0.89. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The business has a fifty day moving average of $92.10 and a two-hundred day moving average of $73.83.

Insider Buying and Selling

In other news, CFO Blake Jeffrey Grayson sold 15,588 shares of the firm’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the completion of the transaction, the chief financial officer now directly owns 85,851 shares of the company’s stock, valued at $8,394,510.78. This trade represents a 15.37 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares in the company, valued at approximately $87,959,967.20. The trade was a 39.08 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 685,773 shares of company stock valued at $66,032,726. Corporate insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

DOCU has been the subject of a number of research analyst reports. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Citigroup raised their target price on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Morgan Stanley increased their price target on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. Wells Fargo & Company lifted their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Friday, December 6th. Finally, UBS Group upped their target price on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.